PROGNOSTIC SIGNIFICANCE OF MINIMAL RESIDUAL DISEASE DETECTED BY MLL FUSION GENE TRANSCRIPTS IN INFANT ACUTE LYMPHOBLASTIC LEUKEMIA. UPDATED RESULTS OF 76 PATIENTS ENROLLED INTO MLL-BABY STUDY

被引：0
|
作者：
Tsaur, G. [1 ]
Popov, A. [2 ]
Riger, T. [1 ]
Solodovnikov, A. [1 ]
Kustanovich, A. [3 ]
Aleinikova, O. [3 ]
Olshanskaya, Y. [2 ]
Myakova, N. [2 ]
Verzhbitskaya, T. [1 ]
Shorikov, E. [4 ]
Streneva, O. [1 ]
Arakaev, O. [1 ]
Vlasova, A. [1 ]
Tsvirenko, S. [5 ]
Saveliev, L. [5 ]
Fechina, L. [1 ]
机构：
[1] Reg Children Hosp 1, Res Inst Med Cell Technol, Ekaterinburg, Russia
[2] Natl Res Inst Pediat Hematol Oncol & Immunol, Moscow, Russia
[3] Belarusian Res Ctr Pediat Oncol Hematol & Immunol, Minsk, BELARUS
[4] PET Technol, Ekaterinburg, Russia
[5] Ural State Med Univ, Ekaterinburg, Russia
来源：
HAEMATOLOGICA | 2017年 / 102卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P161
引用
收藏
页码：30 / 30
页数：1
相关论文
共 50 条
  • [21] The prognostic significance of minimal residual disease in adult Egyptian patients with precursor acute lymphoblastic leukemia
    Samra, Mohamed A.
    Mahmoud, Hossam K.
    Abdelhamid, Thoraya M.
    El Sharkawy, Nahla M.
    Elnahass, Yasser H.
    Elgammal, Mossaad
    Abdelfattah, Rafaat M.
    Eid, Salem
    Ghaleb, Fayek M.
    Kamel, Azza M.
    JOURNAL OF THE EGYPTIAN NATIONAL CANCER INSTITUTE, 2013, 25 (03) : 135 - 142
  • [22] Improved survival of acute lymphoblastic leukemia in infants of more than 6 months of age with MLL gene rearrangement:: Results of the Japan infant leukemia study (MLL96).
    Isoyama, K
    Eguchi, M
    Hibi, S
    Kinukaw, N
    Okawa, H
    Kawasaki, H
    Kosaka, Y
    Oda, T
    Oda, M
    Okamura, T
    Nishimura, S
    Hayashi, Y
    Mori, T
    Imaizumi, M
    Tsukimoto, I
    Kamada, N
    Ishii, E
    BLOOD, 1999, 94 (10) : 296A - 296A
  • [23] CLINICAL OUTCOME AND MONITORING OF MINIMAL RESIDUAL DISEASE (MRD) IN PATIENTS WITH THE MLL-ENL GENETICALLY DEFINED ACUTE LYMPHOBLASTIC LEUKEMIA SUBTYPE
    Cimino, G.
    Elia, L.
    Grammatico, S.
    Rago, A.
    Moleti, L.
    Luciani, M.
    Biondi, A.
    Caraci, M. R.
    Gaidano, G.
    Santoro, L.
    Fanin, R.
    Paoloni, F.
    Vignetti, M.
    Foa, R.
    Mandelli, F.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 : 259 - 259
  • [24] CONCORDANCE OF MINIMAL RESIDUAL DISEASE DETECTION RESULTS OBTAINED BY MULTICOLOR FLOW CYTOMETRY AND PCR OF FUSION GENE TRANSCRIPTS IN CHILDHOOD ACUTE LYMPHOBLASTIC LEUKEMIA
    Popov, A.
    Tsaur, G.
    Verzhbitskaya, T.
    Riger, T.
    Yakovleva, Yu.
    Ivanova, A.
    Druy, A.
    Shorikov, E.
    Saveliev, L.
    Fechina, L.
    ANNALS OF HEMATOLOGY, 2011, 90 : S10 - S11
  • [25] Use of MLL/GRAF fusion mRNA for measurement of minimal residual disease during chemotherapy in an infant acute monoblastic leukemia (AML-M5)
    Wilda, M
    Perez, AV
    Bruch, J
    Woessmann, W
    Metzler, M
    Fuchs, U
    Borkhardt, A
    GENES CHROMOSOMES & CANCER, 2005, 43 (04): : 424 - 426
  • [26] Infants with acute lymphoblastic leukemia and a germline MLL gene are highly curable with use of chemotherapy alone:: results from the Japan Infant Leukemia Study Group
    Nagayama, Jun
    Tomizawa, Daisuke
    Koh, Katsuyoshi
    Nagatoshi, Yoshihisa
    Hotta, Noriko
    Kishimoto, Tomoko
    Takahashi, Yoshihiro
    Kuno, Tomoko
    Sugita, Kanji
    Sato, Takashi
    Kato, Kohji
    Ogawa, Atsushi
    Nakahata, Tatsutoshi
    Mizutani, Shuki
    Horibe, Keizo
    Ishii, Eiichi
    BLOOD, 2006, 107 (12) : 4663 - 4665
  • [27] MINIMAL RESIDUAL DISEASE DETECTION IN CHILDHOOD B-CELL PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA. MULTICOLOR FLOW CYTOMETRY AND PCR OF FUSION GENE TRANSCRIPTS DATA COMPARISON
    Popov, A.
    Tsaur, G.
    Verzhbitskaya, T.
    Riger, T.
    Shorikov, E.
    Saveliev, L.
    Fechina, L.
    HAEMATOLOGICA, 2012, 97 : 8 - 8
  • [28] Prognostic-significance of minimal residual disease after intensive induction therapy in childhood B-lineage acute lymphoblastic leukemia.
    Gruhn, B
    Hongeng, S
    Yi, H
    Hancock, ML
    Rubnitz, JE
    Neale, GAM
    Kitchingman, GR
    BLOOD, 1997, 90 (10) : 1877 - 1877
  • [29] Prognostic and therapeutic significance of leukemia subtypes in the context of risk-directed therapy based on minimal residual disease levels in pediatric acute lymphoblastic leukemia.
    Jeha, Sima
    Choi, John K.
    Pei, Deqing
    Coustan-Smith, Elaine
    Inaba, Hiroto
    Rubnitz, Jeffrey E.
    Ribiero, Raul C.
    Gruber, Tanja A.
    Raimondi, Susana C.
    Karol, Seth E.
    Roberts, Kathryn G.
    Yang, Jun J.
    Cheng, Cheng
    Downing, James R.
    Evans, William E.
    Relling, Mary V.
    Campana, Dario
    Mullighan, Charles G.
    Pui, Ching-Hon
    CANCER RESEARCH, 2021, 81 (13)
  • [30] COMPARISON OF MULTICOLOR FLOW CYTOMETRY AND PCR OF FUSION GENE TRANSCRIPTS APPLICABILITY FOR MINIMAL RESIDUAL DISEASE DETECTION IN CHILDHOOD ACUTE LYMPHOBLASTIC LEUKEMIA
    Popov, Alexander
    Tsaur, Grigory
    Verzhbitskaya, Tatiana
    Riger, Tatiana
    Shorikov, Egor
    Saveliev, Leonid
    Fechina, Larisa
    PEDIATRIC BLOOD & CANCER, 2012, 59 (06) : 1027 - 1027
12345